Lex Orbis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Delhi High Court recently dealt with appeals filed against a single judge’s finding, dismissing rectification petitions filed by Resilient Innovations.

Over the years, we have seen the emergence of many controversial plant patents in India and other jurisdictions. For example, when a plant-related patent for genetically engineered cotton cell lines was granted to Agracetus in 1994, it drew a public outcry and protests from Indian cotton growers.

As a well-planned strategy, joint defence is popular among large patent-holding companies to file patent infringement lawsuits that involve multiple defendants. This is particularly true in cases where a patent holder in the pharmaceutical field seeks to enforce its rights against many generic manufacturers.

The Delhi High Court in India has extended its deadline for inviting opinions on proposed rules concerning its new IP division, in the wake of the dismantling of the Intellectual Property Appellate Board.

While there was no immediate need to abolish a well-established and functional institution such as India’s Intellectual Property Appellate Board, the global trend favours the centralised handling of certain IP disputes such as patents infringements, revocation and appeal cases.